All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


Prevalence and Associated Factors with Anxiety and Depression in Patients with Systemic Lupus Erythematosus in a Moroccan Region

DOI: 10.4236/oalib.1108394, PP. 1-14

Subject Areas: Internal Medicine, Epidemiology, Global Health, Psychiatry & Psychology

Keywords: Systemic Lupus Erythematosus, Anxiety, Depression, Hospital Anxiety and Depression Scale, Morocco

Full-Text   Cite this paper   Add to My Lib


Systemic lupus erythematosus is a chronic autoimmune disease affecting particularly women and is characterized by diverse symptomatology. the main objective of our work is to assess the risk of anxiety and depression and their associated factors in patients with this disease and this is within the framework of a cross-sectional study carried out in the internal medicine department of CHU Hassan II in Fez. Eligible patients were recruited, informed about the study and invited to participate in order to complete a questionnaire providing information on their personal data and evaluating their psychological state using the Hospital Anxiety and Depression Scale (HADs). Statistical analysis was carried out first descriptive, followed by univariate analysis and finally a multivariate analysis to look for factors that may be associated with the risk of anxiety and depression, taking into account possible confounding factors. For this, we included 102 patients, 92.2% of which were women with an average age of 41.6 ± 13.7 years. 55.4% (CI 95%: 45.8% - 65%) suffered from anxiety, which was statistically associated with the low level of study (OR = 2.77; CI 95%: 1.14 - 6.74), the large number of comorbidities (OR = 1.89; CI 95%: 1.18 - 3.03) and with the presence of respiratory manifestations (OR = 4.14; CI 95%: 1.27 - 13.43). Depression was present in 57.4% (95% CI: 47.8% - 67%), this presence was associated with marriage (OR = 4.81; CI 95%: 1.53 - 15.08), low monthly income (OR = 4.44; 1.47 - 13.40), the large number of comorbidities (OR = 1.93; 1.14 - 3.28) and a high number of lupus manifestations (OR = 1.33; 1.03 - 1.73), hence the need to take into account these disorders and to fight against the factors that cause them.

Cite this paper

Harch, I. E. , Benmaamar, S. , Oubelkacem, N. , Jennane, R. , Diagne, B. J. , Maiouak, M. , Chakri, I. , Omari, M. , Otmani, N. , Berraho, M. A. , Fakir, S. E. , Berrady, R. and Tachfouti, N. (2022). Prevalence and Associated Factors with Anxiety and Depression in Patients with Systemic Lupus Erythematosus in a Moroccan Region. Open Access Library Journal, 9, e8394. doi:


[1]  Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., Mejía, J.C., Aydintug, A.O., Chwalinska-Sadowska, H., de Ramón, E., Fernández-Nebro, A., Galeazzi, M., Valen, M., Mathieu, A., Houssiau, F., Caro, N., Alba, P., Ramos- Casals, M., Ingelmo, M., Hughes, G.R.V. and European Working Party on Systemic Lupus Erythematosus (2003) Morbidity and Mortality in Systemic Lupus Erythematosus during a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients. Medicine (Baltimore), 82, 299-308.
[2]  Ghodke-Puranik, Y. and Niewold, T.B. (2015) Immunogenetics of Systemic Lupus Erythematosus: A Comprehensive Review. Journal of Autoimmunity, 64, 125-136.
[3]  Figueiredo-Braga, M., Cornaby, C., Cortez, A., Bernardes, M., Terroso, G., Figueiredo, M., Mesquita, C.D.S., Costa, L. and Poole, B.D. (2018) Depression and Anxiety in Systemic Lupus Erythematosus: The Crosstalk between Immunological, Clinical, and Psychosocial Factors. Medicine (Baltimore), 97, e11376.
[4]  Govoni, M., Bortoluzzi, A., Padovan, M., Silvagni, E., Borrelli, M., Donelli, F., Ceruti, S. and Trotta, F. (2016) The Diagnosis and Clinical Management of the Neuropsychiatric Manifestations of Lupus. Journal of Autoimmunity, 74, 41-72.
[5]  Palagini, L., Mosca, M., Tani, C., Gemignani, A., Mauri, M. and Bombardieri, S. (2013) Depression and Systemic Lupus Erythematosus: A Systematic Review. Lupus, 22, 409-416.
[6]  Iverson, G.L., Sawyer, D.C., McCracken, L.M. and Kozora, E. (2001) Assessing Depression in Systemic Lupus Erythematosus: Determining Reliable Change. Lupus, 10, 266-271.
[7]  Bachen, E.A., Chesney, M.A. and Criswell, L.A. (2009) Prevalence of Mood and Anxiety Disorders in Women with Systemic Lupus Erythematosus. Arthritis & Rheumatology, 61, 822-829.
[8]  Seawell, A.H. and Danoff-Burg, S. (2005) Body Image and Sexuality in Women with and without Systemic Lupus Erythematosus. Sex Roles, 53, 865-876.
[9]  Hawro, T., Krupińska-Kun, M., Rabe-Jablońska, J., Sysa-Jedrzejowska, A., Robak, E., Bogaczewicz, J. and Wozniacka, A. (2011) Psychiatric Disorders in Patients with Systemic Lupus Erythematosus: Association of Anxiety Disorder with Shorter Disease Duration. Rheumatology International, 31, 1387-1391.
[10]  Kwan, A., Katz, P. and Touma, Z. (2019) The Assessment of Anxiety and Depression and Its Associated Factors in SLE. Current Rheumatology Reviews, 15, 90-98.
[11]  McElhone, K., Abbott, J., Shelmerdine, J., Bruce, I.N., Ahmad, Y., Gordon, C., Peers, K., Isenberg, D., Ferenkeh-Koroma, A., Griffiths, B., Akil, M., Maddison, P. and The, L.-S. (2007) Development and Validation of a Disease-Specific Health- Related Quality Of Life Measure, the LupusQol, for Adults with Systemic Lupus Erythematosus. Arthritis & Rheumatology, 57, 972-979.
[12]  Kozora, E., Ellison, M.C. and West, S. (2006) Depression, Fatigue, and Pain in Systemic Lupus Erythematosus (SLE): Relationship to the American College of Rheumatology SLE Neuropsychological Battery. Arthritis & Rheumatology, 55, 628-635.
[13]  Ainiala, H., Loukkola, J., Peltola, J., Korpela, M. and Hietaharju, A. (2001) The Prevalence of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus. Neurology, 57, 496-500.
[14]  Zakeri, Z., Shakiba, M., Narouie, B., Mladkova, N., Ghasemi-Rad, M. and Khosravi, A. (2012) Prevalence of Depression and Depressive Symptoms in Patients with Systemic Lupus Erythematosus: Iranian Experience. Rheumatology International, 32, 1179-1187.
[15]  Nery, F.G., Borba, E.F., Viana, V.S.T., Hatch, J.P., Soares, J.C., Bonfá, E. and Neto, F.L. (2008) Prevalence of Depressive and Anxiety Disorders in Systemic Lupus Erythematosus and Their Association with Anti-Ribosomal P Antibodies. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32, 695-700.
[16]  Sanna, G., Bertolaccini, M.L., Cuadrado, M.J., Laing, H., Khamashta, M.A., Mathieu, A. and Hughes, G.R.V. (2003) Neuropsychiatric Manifestations in Systemic Lupus Erythematosus: Prevalence and Association with Antiphospholipid Antibodies. The Journal of Rheumatology, 30, 985-992.
[17]  Andrade, A.B. and Bosi, M.L.M. (2015) Qualidade do cuidado em dois centros de atenção psicossocial sob o olhar de usuários1. Saúde e Sociedade, 24, 887-900.
[18]  Zhang, L., Fu, T., Yin, R., Zhang, Q. and Shen, B. (2017) Prevalence of Depression and Anxiety in Systemic Lupus Erythematosus: A Systematic Review and Meta- Analysis. BMC Psychiatry, 17, Article No. 70.
[19]  de Almeida Macêdo, E., Appenzeller, S. and Lavras Costallat, L.T. (2017) Assessment of the Hospital Anxiety and Depression Scale (HADS) Performance for the Diagnosis of Anxiety in Patients with Systemic Lupus Erythematosus. Rheumatology International, 37, 1999-2004.
[20]  Mirabelli, G., Cannarile, F., Bruni, C., Vagelli, R., De Luca, R. and Carli, L. (2015) One Year in Review 2015: Systemic Lupus Erythematosus. Clinical and Experimental Rheumatology, 33, 414-425.
[21]  Yilmaz-Oner, S., Oner, C., Dogukan, F.M., Moses, T.F., Demir, K., Tekayev, N., Yilmaz, N., Tuglular, S. and Direskeneli, H. (2015) Anxiety and Depression Predict Quality of Life in Turkish Patients with Systemic Lupus Erythematosus. Clinical and Experimental Rheumatology, 33, 360-365.
[22]  Shen, B., Tan, W., Feng, G., He, Y., Liu, J., Chen, W., Huang, X., Da, Z., Xu, X., Liu, H. and Gu, Z. (2013) The Correlations of Disease Activity, Socioeconomic Status, Quality of Life, and Depression/Anxiety in Chinese Patients with Systemic Lupus Erythematosus. Clinical and Developmental Immunology, 2013, Article ID: 270878.
[23]  Zigmond, A.S. and Snaith, R.P. (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.
[24]  Botega, N.J., Bio, M.R., Zomignani, M.A., Garcia Junior, C. and Pereira, W.A.B. (1995) Transtornos do humor em enfermaria de clínica médica e validaçäo de escala de medida (HAD) de ansiedade e depressäo. Revista de Saúde Pública, 29, 355-363.
[25]  Greco, C.M., Kao, A.H., Sattar, A., Danchenko, N., Maksimowicz-McKinnon, K.M., Edmundowicz, D., Sutton-Tyrrell, K., Tracy, R.P., Kuller, L.H. and Manzi, S. (2009) Association between Depression and Coronary Artery Calcification in Women with Systemic Lupus Erythematosus. Rheumatology (Oxford), 48, 576-581.
[26]  Stubbs, B., Aluko, Y., Myint, P.K. and Smith, T.O. (2016) Prevalence of Depressive Symptoms and Anxiety in Osteoarthritis: A Systematic Review and Meta-Analysis. Age Ageing, 45, 228-235.
[27]  Zhang, L., Xia, Y., Zhang, Q., Fu, T., Yin, R., Guo, G., Li, L. and Gu, Z. (2017) The Correlations of Socioeconomic Status, Disease Activity, Quality of Life, and Depression/Anxiety in Chinese Patients with Rheumatoid Arthritis. Psychology, Health & Medicine, 22, 28-36.
[28]  Westhoff, G., Dörner, T. and Zink, A. (2012) Fatigue and Depression Predict Physician Visits and Work Disability in Women with Primary Sjögren’s Syndrome: Results from a Cohort Study. Rheumatology, 51, 262-269.
[29]  Lou, Q.-Y., et al. (2021) Associations of FKBP4 and FKBP5 Gene Polymorphisms with Disease Susceptibility, Glucocorticoid Efficacy, Anxiety, Depression, and Health- Related Quality of Life in Systemic Lupus Erythematosus Patients. Clinical Rheumatology, 40, 167-179.
[30]  Shinozaki, G., et al. (2011) Relationship between FKBP5 Polymorphisms and Depression Symptoms among Kidney Transplant Recipients. Depression and Anxiety, 28, 1111-1118.
[31]  Binder, E.B., Salyakina, D., Lichtner, P., Wochnik, G.M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M.A., Nickel, T., Künzel, H.E., Fuchs, B., Majer, M., Pfennig, A., Kern, N., Brunner, J., Modell, S., Baghai, T., Deiml, T., Zill, P., Bondy, B., Rupprecht, R., Messer, T., Köhnlein, O., Dabitz, H., Brückl, T., Müller, N., Pfister, H., Lieb, R., Mueller, J.C., Lõhmussaar, E., Strom, T.M., Bettecken, T., Meitinger, T., Uhr, M., Rein, T., Holsboer, F. and Muller-Myhsok, B. (2004) Polymorphisms in FKBP5 Are Associated with Increased Recurrence of Depressive Episodes and Rapid Response to Antidepressant Treatment. Nature Genetics, 36, 1319-1325.
[32]  Roberts, S., Keers, R., Breen, G., Coleman, J.R.I., Jöhren, P., Kepa, A., Lester, K.J., Margraf, J., Scheider, S., Teismann, T., Wannemüller, A., Eley, T.C. and Wong, C.C.Y. (2019) DNA Methylation of FKBP5 and Response to Exposure-Based Psychological Therapy. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 180, 150-158.
[33]  Hirakawa, H., Akiyoshi, J., Muronaga, M., Tanaka, Y., Ishitobi, Y., Inoue, A., Oshita, H., Aizawa, S., Masuda, K., Higuma, H., Kanehisa, M., Ninomiya, T. and Kawano, Y. (2016) FKBP5 Is Associated with Amygdala Volume in the Human Brain and Mood State: A Voxel-Based Morphometry (VBM) Study. International Journal of Psychiatry in Clinical Practice, 20, 106-115.
[34]  Waheed, A., Hameed, K., Khan, A.M., Syed, J.A. and Mirza, A.I. (2006) The Burden of Anxiety and Depression among Patients with Chronic Rheumatologic Disorders at a Tertiary Care Hospital Clinic in Karachi, Pakistan. Journal of Pakistan Medical Association, 56, 243-247.
[35]  Meszaros, Z.S., Perl, A. and Faraone, S.V. (2012) Psychiatric Symptoms in Systemic Lupus Erythematosus: A Systematic Review. Journal of Clinical Psychiatry, 73, 993- 1001.
[36]  Trupin, L., Tonner, M.C., Yazdany, J., Julian, L.J., Criswell, L.A., Katz, P.P. and Yelin, E. (2008) The Role of Neighborhood and Individual Socioeconomic Status in Outcomes of Systemic Lupus Erythematosus. The Journal of Rheumatology, 35, 1782-1788.
[37]  Xie, X., Wu, D. and Chen, H. (2016) Prevalence and Risk Factors of Anxiety and Depression in Patients with Systemic Lupus Erythematosus in Southwest China. Rheumatology International, 36, 1705-1710.
[38]  Alsowaida, N., Alrasheed, M., Mayet, A., Alsuwaida, A. and Omair, M.A. (2018) Medication Adherence, Depression and Disease Activity among Patients with Systemic Lupus Erythematosus. Lupus, 27, 327-332.
[39]  Ishikura, R., Morimoto, N., Tanaka, K., Kinukawa, N., Yoshizawa, S., Horiuchi, T., Nakashima, H. and Otsuka, T. (2001) Factors Associated with Anxiety, Depression and Suicide Ideation in Female Outpatients with SLE in Japan. Clinical Rheumatology, 20, 394-400.
[40]  Chin, C.N., Cheong, I. and Kong, N. (1993) Psychiatric Disorder in Malaysians with Systemic Lupus Erythematosus. Lupus, 2, 329-332.
[41]  Walker, S.E., Smarr, K.L., Parker, J.C., Weidensaul, D.N., Nelson, W. and McMurray, R.W. (2000) Mood States and Disease Activity in Patients with Systemic Lupus Erythematosus Treated with Bromocriptine. Lupus, 9, 527-533.
[42]  Nery, F.G., Borba, E.F., Hatch, J.P., Soares, J.C., Bonfá, E. and Neto, F.L. (2007) Major Depressive Disorder and Disease Activity in Systemic Lupus Erythematosus. Clinical Rheumatology, 48, 14-19.
[43]  Karol, D.E., Criscione-Schreiber, L.G., Lin, M. and Clowse, M.E.B. (2013) Depressive Symptoms and Associated Factors in Systemic Lupus Erythematosus. Psychosomatics, 54, 443-450.
[44]  Julian, L.J., Gregorich, S.E., Tonner, C., Yazdany, J., Trupin, L., Criswell, L.A., Yelin, E. and Katz, P.P. (2011) Using the Center for Epidemiologic Studies Depression Scale to Screen for Depression in Systemic Lupus Erythematosus. Arthritis Care & Research (Hoboken), 63, 884-890.
[45]  Hanly, J.G., Fisk, J.D., McCurdy, G., Fougere, L. and Douglas, J.-A. (2005) Neuropsychiatric Syndromes in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis. The Journal of Rheumatology, 32, 1459-1456.
[46]  Hanly, J.G., Su, L., Farewell, V., McCurdy, G., Fougere, L. and Thompson, K. (2009) Prospective Study of Neuropsychiatric Events in Systemic Lupus Erythematosus. The Journal of Rheumatology, 36, 1449-1459.
[47]  Lisitsyna, T.A., Vel’tishchev, D.I., Seravina, O.F., Kovalevskaia, O.B., Marchenko, A.S., Novikova, D.S., Novikov, A.A., Aleksandrova, E.N. and Nasonov, E.L. (2009) Prevalence of Mental Disorders in SLE Patients: Correlations with the Disease Activity and Comorbid Chronic Conditions. Terapevticheskii Arkhiv, 81, 10-16.


comments powered by Disqus

Contact Us


WhatsApp +8615387084133

WeChat 1538708413